View Full Company Profile

Range Capital Acquisition Corp.

CIK: 2035644 Filed: March 25, 2026 10-K

Key Highlights

  • Successfully raised $115.5 million in capital for acquisition purposes.
  • Targeting high-growth sectors including Nuclear Energy, Defense Tech, and Women’s Health.
  • Experienced leadership team with a track record of taking companies public.
  • Strategic focus on North American companies with valuations of at least $500 million.

Financial Analysis

Range Capital Acquisition Corp. Annual Report - How They Did This Year

I’ve put together this guide to help you understand how Range Capital Acquisition Corp. performed this year. My goal is to explain their financial filings in plain English so you can decide if this investment fits your strategy.

1. What does this company do?

Range Capital is a "Special Purpose Acquisition Company," or SPAC. Think of it as a "blank check" company. It doesn't sell products or services. Instead, it raised money from investors to find a private company to buy. Once they merge, that private company becomes a public business on the Nasdaq. Right now, Range Capital is a "shell" company actively searching for that perfect partner.

2. Financial performance

Since they don't sell products, they don't have revenue. Their performance is defined by how they manage the cash they raised. They secured $115.5 million by selling 11.5 million units at $10.00 each. This capital sits in a trust account, invested in safe government securities. They spent approximately $1.2 million on legal, accounting, and administrative costs to keep the company operational while they hunt for a target.

3. What are they looking for?

The team is hunting for a partner with these specific traits:

  • Unique Assets: Businesses with technology or intellectual property that is difficult to replicate.
  • "Pure Plays": Companies focused on one specific market rather than a complex conglomerate.
  • Strong Potential: They are prioritizing sectors like Nuclear Energy, Defense Tech, Specialty Finance, and Women’s Health.
  • Size: They are targeting North American companies with a valuation of at least $500 million.

4. Major wins and changes

  • Successful Fundraising: Investors showed strong interest, and the company successfully raised the full $115.5 million.
  • Leadership Update: In August 2025, they hired Andrew Kucharchuk as Chief Financial Officer to lead the financial review of potential targets.
  • Management's Track Record: CEO Tim Rotolo has experience taking companies public. It is worth noting that he also manages a second SPAC, which means his time and focus are divided between two different entities.

5. Key risks

  • The "Clock": They have 18 to 24 months to find a company to buy. If they fail to complete a merger within this window, they must return the money (plus interest) to shareholders.
  • No Business Yet: You are betting entirely on the management team's ability to find a deal. There is no past sales data or operational history to analyze.
  • Conflicts of Interest: Because the team runs multiple SPACs, there is a possibility that they could prioritize the best deals for their other companies first.
  • Limited Disclosure: They operate under rules that allow them to share less financial information than larger, established public companies, which makes it harder to compare them to other stocks.

6. Future outlook

The team is currently in the "search" phase. They believe they offer a faster, more reliable path to the stock market than a traditional IPO. Their goal for the next year is to identify a target, sign a merger agreement, and secure shareholder approval.


Investor Tip: Since this is a "blank check" company, your investment is essentially a bet on the management team's ability to find a high-quality business at a fair price. Before deciding, consider whether you are comfortable with the risks of a pre-revenue company and the potential for management's focus to be split across multiple projects. I will update this guide as we learn more about their search progress.

Risk Factors

  • The 'Clock' risk: Failure to complete a merger within 18-24 months forces a return of capital to shareholders.
  • Management conflict of interest due to the CEO managing multiple SPACs simultaneously.
  • Lack of operational history or revenue, making the investment entirely dependent on management's deal-sourcing ability.
  • Limited financial disclosure requirements compared to traditional public companies.

Why This Matters

Stockadora surfaced this report because Range Capital sits at a critical inflection point: they have the capital and a new CFO, but they are racing against a strict 24-month deadline. For investors, this is a pure play on management's ability to execute in a crowded SPAC market.

What makes this filing stand out is the specific focus on high-barrier sectors like Nuclear Energy and Defense. It signals a departure from generic SPAC targets, suggesting the leadership is hunting for high-value, defensible assets rather than just any available deal.

Financial Metrics

Total Capital Raised $115.5 million
Units Issued 11.5 million
Issue Price per Unit $10.00
Operating Expenses $1.2 million
Target Valuation $500 million+

About This Analysis

AI-powered summary derived from the original SEC filing.

Document Information

Analysis Processed

March 26, 2026 at 02:21 AM

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.